5-Amino-1MQ

Certificate of Analysis & Complete Test Results

✓ Verified & Certified
Test Date
Jan 30, 2026
Batch Number
110038
Purity Level
99.27%

Certificate of Analysis

High-Performance Liquid Chromatography

Client: Peptides Canada
Sample Name: HGH Fragment 176-191
Batch #: 110038
Report Date: 10/07/2025
Test: Purity
Receipt Date: 10/06/2025
Analysis Date: 10/07/2025
Matrix: Powder
Number of samples: 1
Purity: 99.27%

Research-grade specification: ≥95.0% — this batch exceeds specification.

Date File 110038_MS2_posneg_HGH Frag_176_191_Lot110038_purity.d Sample Name HGH Frag_176_191_Lot110038_purity
Sample Type Sample Position P2-79
Instrument Name LCMS-7800 Series Username -
Acq Method HGH Frag176_191_purity_5mg.m Acquired 10/07/2025 09:55:41 AM
IRM Calibration Status Calibrated Time (UTC-07:00)
Comment Sample test for purity of HGH Fragment 176-191 batch 110038 DA Method SignalToNoiseCheckout.m
Sample Group Test Batch 6 Info. -
Stream Name LC1 Acquisition 10/07/2025 09:55:41 AM
Acquisition SW Version 6400 Series Triple Quadrupole B.09.00 (89037.0) Time (Local) (UTC-07:00)

Peak List

Time Area % Area
6.10 min 5043.8 99.27 %
7.82min 39.7 0.73 %

* determined as HGH Fragment 176-191 based on retention time

Note: Percent area between two compounds is not quantitative due to variable extinction coefficients.

Test Screen

UV Chromatogram:

Identity: HGH Fragment 176-191

(Other names: HGH Frag 176-191, Lipolytic Fragment, AOD-9604)

CAS: 66004-57-7

Data

Mass Spectrum

MSMS ID — head to tail database matching

Mass Spectrum Peptide Envelope encompasses the 2-5 positive change states conferring Peptide Mass

HGH Fragment 176-191

Expected Mass: 1815.0

Observed Mass: 1815.1

Reviewed and approved by:

Herman Lelie

Pepslab.ca LLC. All test results are the responsibility of the client. This report relates only to the samples tested. The analyses were performed except as indicated. Samples are within quality control criteria and area specifications unless noted.